Fig. 4From: IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy[The prognosis prediction of IGSF11 and VISTA in various tumors]. The top half shows the poor prognosis prediction and possible relevant factors of IGSF11 and VISTA, the bottom half indicates the favorable prognosis prediction and possible relevant factors of VISTA, in various tumorsBack to article page